secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001493152-23-025013
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology announces $3.5M registered direct offering at $6.00/share with warrants
--------------------------------------------------------------------------------

- Issued 583,334 shares (or equivalents) at $6.00/share plus warrants for 583,334 shares at $6.00, expiring 5 years.
- Gross proceeds ~$3.5M; placement agent A.G.P./Alliance Global Partners receives 6.0% fee and warrants at $6.60.
- Common stock offered via effective shelf registration S-3 (No. 333-252430); warrants issued in private placement under Section 4(a)(2).
- Closing expected July 20, 2023; 90-day lockup on further sales and 180-day prohibition on variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223025013/0001493152-23-025013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223025013/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer